Pembrolizumab for metastatic adrenocortical carcinoma with high mutational burden: Two case reports. [electronic resource]
Producer: 20190104Description: e13517 p. digitalISSN:- 1536-5964
- Adrenal Cortex Neoplasms -- drug therapy
- Adrenocortical Carcinoma -- drug therapy
- Adult
- Antibodies, Monoclonal, Humanized -- therapeutic use
- Antineoplastic Agents, Immunological -- therapeutic use
- DNA Mismatch Repair -- genetics
- Female
- Humans
- MutS Homolog 2 Protein -- genetics
- Mutation
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Journal Article
There are no comments on this title.
Log in to your account to post a comment.